Skip to main content
Terug
KMTS logo

KESTRA MEDICAL TECHNOLOGIES, LTD.

Datakwaliteit: 100%
KMTS
NASDAQ Healthcare Medical - Instruments & Supplies
€ 19,59
▲ € 0,49 (2,57%)
Marktkapitalisatie: 1,14B
Dagbereik
€ 17,86 € 19,77
52-Weeksbereik
€ 13,25 € 30,00
Volume
474.906
50D / 200D Gem.
€ 23,97 / € 22,08
Vorige Slotkoers
€ 19,10

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (626 peers)

Metriek Aandeel Sector Mediaan
P/E -10,1 0,4
P/B 5,6 2,9
ROE % 3,7
Net Margin % -190,3 3,8
Rev Growth 5Y % 10,0
D/E 0,2 0,2

Belangrijkste Punten

Debt/Equity of 0,22 — conservative balance sheet
Negative free cash flow of -101,20M
Capital intensive — 39,44% of revenue goes to capex

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)115,05%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROIC-31,95%
Net Margin-190,28%
Op. Margin-177,85%

Veiligheid

Debt / Equity
0,22
Current Ratio6,72
Interest Coverage-13,75

Waardering

P/E Ratio
-10,05
P/B Ratio5,57
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 115,05% Revenue Growth (3Y) 179,99%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 59,82M Net Income (TTM) -113,81M
ROE N/A ROA -38,48%
Gross Margin 40,47% Operating Margin -177,85%
Net Margin -190,28% Free Cash Flow (TTM) -101,20M
ROIC -31,95% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,22 Current Ratio 6,72
Interest Coverage -13,75 Dividend Yield 0,00%
Valuation
P/E Ratio -10,05 P/B Ratio 5,57
P/S Ratio 19,12 PEG Ratio -0,07
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 1,14B Enterprise Value 950,25M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2020
Revenue 59,82M 27,81M 7,63M 0,0 0,0
Net Income -113,81M -94,12M -84,24M -34,10M -29,47M
EPS (Diluted) -5,13 -2,04 -1,75 -0,69 -0,59
Gross Profit 24,21M 362.000,0 -10,65M 0,0 0,0
Operating Income -106,38M -85,06M -80,42M -32,71M -29,32M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2020
Total Assets 295,74M 45,95M 38,66M 30,52M 7,87M
Total Liabilities 90,34M 255,33M 156,23M 28,76M 4,02M
Shareholders' Equity 205,41M -209,38M -117,58M 1,77M 3,86M
Total Debt 44,31M 45,17M 39,13M 22,85M 452.000,0
Cash & Equivalents 237,60M 8,25M 14,81M 24,34M 5,76M
Current Assets 255,33M 14,91M 18,42M 26,20M 6,17M
Current Liabilities 37,98M 32,97M 36,74M 6,61M 4,02M